Jae-Seob Kim

Dr. Jae-Seob Kim is a Co-CEO, Director & Head-Management at N2TECH Co., Ltd., a CEO, Director & Head-Management at APTN, Inc., a Co-Chief Executive Officer & Director at Aprogen Biologics, Inc., a Chief Executive Officer & Director at Aprogen, Inc. and a Chief Executive Officer at G Base Co., Ltd. He is on the Board of Directors at N2TECH Co., Ltd., APTN, Inc., Aprogen Biologics, Inc., Aprogen, Inc., APTOCROM, Inc. and E&M Revolution Co., Ltd. Dr. Kim was previously employed as a Chief Executive Officer by Aprogen Medicines, Inc., a Chief Executive Officer & Director by APTOCROM, Inc., a Chief Executive Officer & Director by Aprogen, Inc. /Old/, a Director & Head-Biopharmaceutical Business by Aprogen Biologics, Inc., a Chief Executive Director by Aprogen Biologics, Inc. (Korea), a Non-Executive Director by DiNonA, Inc., and a Professor-Biological Science by Korea Advanced Institute of Science & Technology.
He also served on the board at Chunggei Pharm Co. Ltd. He received his undergraduate degree from the University of Wisconsin, an undergraduate degree from Seoul National University, a graduate degree from Seoul National University and a doctorate degree from Seoul National University.